The World and Türkiye in 2025

Aydın Tiryaki (December 31, 2025)
(Gemini AI was used as a data compilation and writing assistant)

Abstract: The year 2025 has been a year where medical technologies reached their peak, yet the inequality in access to these technologies and operational errors also deepened. This article analyzes the practical constraints of theoretical revolutions such as cancer vaccines and artificial intelligence, the ethical and technical dimensions of health tourism in Türkiye, and the structural failures within the global health system.

Introduction: The Line Between Hope and Reality

As we bid farewell to 2025, the medical world is undergoing a serious test in transforming laboratory successes into clinical prevalence. Many “miraculous” developments gracing the headlines are not yet accessible to the vast majority of the world’s population due to high costs and logistical hurdles. 2025 has gone down in history as a year that questioned not just “what medicine can do,” but “how fairly it can provide these gains to society as a whole.”

1. Cancer Vaccines and the Accessibility Deadlock

While mRNA-based cancer vaccines achieved great scientific success in 2025, their impact on daily life remains limited.

• Economic Barrier: The astronomical costs of these personalized vaccines make the treatment an option only for the highest-income segments.
• Logistical Inadequacy: The ultra-cold chain and advanced laboratory infrastructure required by mRNA technology make the practical application of this treatment nearly impossible in developing and underdeveloped countries.

2. Artificial Intelligence: Diagnostic Capacity and Ethical Risks

The inclusion of artificial intelligence in diagnostic processes gained significant momentum in 2025 but brought new problems along with it.

• Data Bias: The fact that algorithms are mostly trained on data sets from specific geographies has increased the risk of misdiagnosis in different demographic groups.
• Uncertainty of Legal Responsibility: Who bears the responsibility for medical errors in AI-supported decisions—the doctor, the developer, or the institution—remains one of the largest unresolved legal gaps of 2025.

3. Health Tourism in Türkiye: Quantity, Quality, and Ethical Issues

The volume of approximately 2.3 million patients reached by Türkiye in health tourism may seem like a sectoral success, but it has placed significant pressure on the system.

• Service Quality and Follow-up Problems: Especially in aesthetic and dental procedures, a focus on rapid results makes it difficult to manage complications that arise after patients return to their countries. This has led to an increase in case reports damaging the international reputation of the Turkish health sector.
• Domestic Market and Brain Drain: The high foreign exchange income generated by health tourism has accelerated the transition of qualified specialists from public hospitals to the private sector. This has made it difficult for local citizens in Türkiye to access qualified specialists in state hospitals, pushing appointment times months into the future in certain branches.
• Regulation Gaps: Despite increased inspections, medical tragedies caused by unauthorized clinics—often referred to as “under-the-counter” operations—continue to be the greatest risk factor for the future of the sector.

4. The Global Health Gap: Billions Left Behind

WHO reports at the end of 2025 show that approximately 55% of the world’s population still lacks regular access to even the most basic medicines and treatment services. While revolutions in medical technology extend life expectancy in developed countries, the continuation of deaths from preventable diseases in the Global South is the most painful paradox of 2025.

Conclusion

The year 2025 has been a theoretically promising year in medicine, but a sobering one in terms of practical application and ethical distribution. The vision for Türkiye in 2026 should be not only to increase the number of foreign patients but to strictly implement quality standards and inspections in health tourism while developing balanced public policies to prevent this economic activity from harming the local healthcare system.

APPENDIX: AN ACCOUNTING OF TECHNOLOGICAL LEAPS AND HUMAN CRISES IN HEALTH

While the medical revolutions and health tourism data discussed in this article demonstrate how far medicine has progressed in 2025, they cannot hide the fact that this progress is not reflected equally in all segments and that serious cracks have formed in the human side of the system. The reality beyond the data should be noted with the following headings:

1. The Paradox of Technology and Inequality in Global Health In 2025, AI-supported diagnostic systems and personalized cancer vaccines revolutionized global medical literature. However, the fact that access to these technologies remains exclusive to certain income groups or developed countries has created a risk of global “health apartheid.” What modern medicine truly requires is not just technological inventions, but the fair distribution of these innovations.

2. Türkiye: Success in Health Tourism vs. Exhaustion in the Public System Türkiye has become one of the few leading centers in health tourism globally in 2025, providing a significant foreign exchange inflow to the national economy. However, this glittering picture in the private sector contrasts with the congestion and difficulties in making appointments in the public health system. The transformation of health services into an “export item” can sometimes push the local population’s requirement for quality and rapid health services to the background.

3. Physician Migration and the Meritocracy Crisis The deepest wound of the health system is the ongoing tendency of well-trained and qualified physicians to go abroad in 2025. Difficulties in working conditions, incidents of violence in healthcare, and the fact that criteria other than merit are taken as a basis in academic and administrative staff cause our national health memory to lose ground. Building the best hospitals will not ensure sustainable success unless you can protect the meritocratic human resources within them.

4. Access to Medicine and the Requirement for National Production Disruptions in the global supply chain and economic constraints led to periodic crises in accessing critical medicines in 2025. Reaching national self-sufficiency in this area for Türkiye is not just an economic choice but a matter of security. Supporting meritocratic R&D teams in the pharmaceutical industry stands before us as the most fundamental requirement to reduce foreign dependency.

---

A Note on Methods and Tools: All observations, ideas, and solution proposals in this study are the author’s own. AI was utilized as an information source for researching and compiling relevant topics strictly based on the author’s inquiries, requests, and directions; additionally, it provided writing assistance during the drafting process. (The research-based compilation and English writing process of this text were supported by AI as a specialized assistant.)